Glioma & Astrocytoma in Adults

We have experience in treating the most complex types of gliomas and astrocytomas. Our nationally known team of neurosurgeons, neuro-oncologists, radiologists, radiation oncologists, and neuropathologists partners to create a customized treatment plan for you.

Your team of specialists uses sophisticated diagnostic techniques, such as advanced MRI and precision molecular diagnosis, which determines the tumor’s specific molecular makeup.

Treatment may include targeted drugs, immunotherapy, and treatments provided through cutting-edge clinical trials. We also offer Gamma Knife® radiosurgery, a targeted treatment that provides an alternative to surgery and radiation therapy. Ultimately, we personalize a care plan just for you.

Clinical Trials and Research Studies

Phase 2

CDA Chi BMS A phase II trial of nivolumab ipilimumab and short course radiotherapy in newly diagnosed glioblastoma patients with unmethylated MGMT promoter BMS-936558 and BMS-734016

Phase 2/3

A Phase 2/3 Randomized Open-Label Study of Toca 511 a Retroviral Replicating Vector Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA (Toca5)

Phase 1/2

Phase I-II Study of MEK 162 for Children with Low-Grade Gliomas and Other Ras/Raf/ERK Pathway Activated Tumors

Phase 2

A phase II open-label multicenter study of ONC201 in adults with recurrent histone H3 K27M mutant glioma